InsidersTradesSigma
Track the 대웅제약 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 대웅제약 has logged 2 public disclosures. Market capitalisation: €1,460.1bn. The latest transaction was filed on 27 March 2026 (Sale). Among the most active insiders: 대웅. Every trade is free.
Analysts rate 대웅제약 Buy (bullish), based on 9 analysts. Average price target: ₩207,778.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Daewoong Pharmaceutical es una empresa farmacéutica surcoreana centrada en el desarrollo y la fabricación de medicamentos. Cotiza en la XKRX.